Free Trial

NOVONIX (NASDAQ:NVX) Trading Down 1.8% - Here's What Happened

NOVONIX logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • NOVONIX shares fell 1.8% to $0.8046 on Tuesday (intraday low $0.7951) with 224,475 shares traded — down about 28% versus the average session volume; the 50‑day and 200‑day moving averages are $0.80 and $1.14, respectively.
  • Research firms have a consensus Sell on NVX, with recent downgrades and a Weiss Ratings restatement to "sell (e+)."
  • Fundamentals remain weak: the company reported a ($0.22) EPS loss and $1.4 million in quarterly revenue, institutional ownership is only 0.06%, though Bank of America notably increased its stake.
  • MarketBeat previews the top five stocks to own by May 1st.

NOVONIX Limited Sponsored ADR (NASDAQ:NVX - Get Free Report) shares traded down 1.8% during trading on Tuesday . The stock traded as low as $0.7951 and last traded at $0.8046. 224,475 shares were traded during mid-day trading, a decline of 28% from the average session volume of 313,639 shares. The stock had previously closed at $0.8194.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on NVX shares. Weiss Ratings restated a "sell (e+)" rating on shares of NOVONIX in a research note on Thursday, January 22nd. Wall Street Zen downgraded NOVONIX from a "hold" rating to a "sell" rating in a research note on Saturday, March 7th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of "Sell".

Get Our Latest Report on NOVONIX

NOVONIX Trading Down 1.8%

The company has a 50 day moving average of $0.80 and a two-hundred day moving average of $1.14. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.04 and a current ratio of 1.07.

NOVONIX (NASDAQ:NVX - Get Free Report) last announced its earnings results on Thursday, January 29th. The company reported ($0.22) earnings per share for the quarter. The company had revenue of $1.40 million during the quarter.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in NVX. GK Wealth Management LLC purchased a new stake in NOVONIX during the 4th quarter valued at about $26,000. Southeast Asset Advisors LLC purchased a new stake in NOVONIX during the 3rd quarter valued at about $35,000. OLD Mission Capital LLC purchased a new stake in NOVONIX during the 4th quarter valued at about $32,000. Susquehanna International Group LLP purchased a new stake in NOVONIX during the 3rd quarter valued at about $65,000. Finally, Bank of America Corp DE grew its stake in NOVONIX by 335.1% during the 3rd quarter. Bank of America Corp DE now owns 72,972 shares of the company's stock valued at $93,000 after purchasing an additional 56,200 shares during the last quarter. 0.06% of the stock is currently owned by hedge funds and other institutional investors.

About NOVONIX

(Get Free Report)

NOVONIX, trading under the NASDAQ ticker NVX, is a technology-driven company specializing in the development and production of advanced materials and testing solutions for the lithium-ion battery industry. The company's primary focus lies in supplying high-purity synthetic graphite anode materials and delivering comprehensive battery testing services to original equipment manufacturers (OEMs), research institutions, and battery producers worldwide. NOVONIX operates through two core divisions: NOVONIX Materials & Technology, which produces battery-grade graphite, and NOVONIX Battery Testing Solutions, which offers hardware and software platforms designed to accelerate battery research and development.

The Materials & Technology business segment manufactures spherical synthetic graphite anode products that meet rigorous industry standards for performance, consistency, and scalability.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in NOVONIX Right Now?

Before you consider NOVONIX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NOVONIX wasn't on the list.

While NOVONIX currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines